Submitting OIG:
Date Issued:
Monday, September 18, 2023
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
OEI-01-20-00240
Component, if applicable:
Food and Drug Administration
Food and Drug Administration
Location(s):
United States
Type of Report:
Inspection / Evaluation
Questioned Costs:
$0
Funds for Better Use:
$0
Number of Recommendations:
2
Report updated under NDAA 5274:
No
View Document:
Attachment | Size |
---|---|
OEI-01-20-00240.pdf | 3.38 MB |